Dementia Is Associated With Open-Angle Glaucoma
Currently available large epidemiologic data regarding the association between OAG and dementia were all obtained from Western populations, and results are controversial. In a longitudinal study using nationwide case register data of patients who had been hospitalized in Denmark, Kessing et al found that OAG was not associated with an increased risk of subsequent AD. However, the cases and controls were not matched in terms of sociodemographic characteristics or medical comorbidities, and there may have been a selection bias for patients with more-severe OAG. Similarly, Ou et al, using US Medicare claims data, also showed no increased risk of developing dementia after a diagnosis of OAG in nationally representative longitudinal cohorts of elderly persons. Ekström further identified a null association between OAG and AD in a population survey in the municipality of Tierp, Sweden. On the contrary, in a population-based longitudinal study in a French city that actively screened for glaucoma and dementia in elderly adults, Helmer et al showed a positive association between OAG and subsequent dementia. However, the study population mainly consisted of well-educated subjects and therefore the results might not be applicable to less-educated populations. To our best knowledge, this study is the first population-based study to investigate an epidemiologic association between OAG and dementia, after adjusting for patient sociodemographic characteristics and comorbid medical disorders in an Asian population. Consistent with the findings of Helmer et al, we demonstrated that a statistically significant higher proportion of prior OAG was found among dementia patients compared with the controls, which supports a possible association between OAG and dementia.
The actual mechanisms contributing to the association between OAG and dementia are not fully understood. There is an ample evidence suggesting that vascular risk factors including hypertension, diabetes, and hyperlipidemia are associated with cognitive impairment and increase the risk of AD and vascular dementia. Vascular risk factors contributing to vascular dysregulation and microvascular damage are also increasingly acknowledged as potential risk factors for the development and progression of OAG. Thus, a possible explanation regarding the association between OAG and dementia is that both diseases share common vascular risk factors. Our analysis adjusted for hypertension, diabetes, hyperlipidemia, and other vascular risk factors such as tobacco and alcohol use. It was suggested that vascular risk factors are not the sole mechanism contributing to the association between OAG and dementia.
In experimental studies using rat models, neurotoxic amyloid-β (Aβ), the core element of amyloid plaques in the AD brain, exhibited abnormal aggregation in retinal ganglion cells of eyes affected by elevated IOP. Activation of caspases, a group of proteases essential for apoptosis, that cleave amyloid precursor proteins into neurotoxic Aβ was also demonstrated in an ocular hypertensive model of rat glaucoma, implying a role of Aβ neurotoxicity in retinal ganglion cell death and the pathogenesis of glaucoma. Furthermore, there is emerging evidence that abnormal hyperphosphorylation of the microtubule-associated tau protein, a crucial injury marker of neuronal integrity and axonal transport in neurodegenerative diseases such as AD, was found in the retina of human glaucoma patients with elevated IOP. The presence of neurotoxic Aβ and hyperphosphorylated tau, major hallmarks of AD, in experimental rat and human retinas with elevated IOP, respectively, underscores the similarities between these two age-related neurodegenerative diseases at the molecular level. In addition to elevated IOP, decreased cerebrospinal fluid pressure, observed in a substantial proportion of patients with AD, results in an abnormal high trans-lamina cribrosa pressure difference and contributes to the development of glaucomatous damage to the optic nerve, suggesting a potential link between AD and OAG.
Another possible mechanism that links OAG to dementia is the severe vision loss and blindness caused by OAG in the elderly. Serious visual impairment, deprivation of an important structure critical for sensory input, is associated with limitations of the activities of daily living, and handicaps in physical and mental leisure activities, which may be helpful in enhancing the complexity of neuronal synapses, improving cognitive reserves, and eventually bringing about or aggravating cognitive impairment or dementia in older people. In addition, as the disease progresses, older people with visual impairment due to glaucoma are significantly afflicted by substantial psychological suffering, a poor quality of life, and depression, which are potential risk factors for AD and dementia. It is worth noting that female but not male dementia patients were more likely to have prior OAG than controls in our study. This observation can partially be explained by the gender effect in the progression of visual impairment due to glaucoma, and the lines of evidence show that older women are at greater risk for glaucoma vision loss. The mechanisms behind this may be a decline in female sex hormones after menopause, which may influence the IOP, increase vascular resistance, and hamper ocular blood flow to the optic nerve. As glaucoma more rapidly deteriorates in aged women, they are at a higher risk for dementia than men. As women exceed men in rapidly growing dementia populations, further research is needed to clarify the role of gender effects on the relationship between glaucoma and dementia.
A particular strength of this study is the use of a nationwide population-based data set that provided a sufficient sample size and statistical power to explore the association between OAG and dementia. However, the findings of this study need to be interpreted in the context of the following limitations. First, OAG and dementia diagnoses, which rely on administrative claims data and ICD codes, may be less precise than those made according to standardized diagnostic procedures including ophthalmologic and neuropsychological examinations. To avoid miscoding and increase the diagnostic accuracy, we selected patients who had at least two consensus diagnoses of OAG or dementia, and only dementia cases who were diagnosed by a certified neurologist or psychiatrist or only OAG cases who received prescriptions for topical antiglaucoma medication were included in the study. In order to address the appropriateness of using the applied coding approach, sensitivity analyses were performed using different definitions. We thus selected all subjects (n=17 292) who had received at least one diagnosis of dementia in their ambulatory care claims. We found that although the association magnitude decreased, there was still a significant association between dementia and OAG (adjusted OR=1.37 95% CI=1.28–1.46). In addition, to preclude inaccurate medical claims, the NHI Bureau of Taiwan randomly samples a fixed percentage of claims data with review and scrutiny of chart records from every hospital, followed by heavy penalties if outlier practice or malpractice is discovered. In addition, several previous studies determined that the NHI Research Database is of acceptable quality to provide reasonable estimates for epidemiological studies of OAG and dementia. Second, the administrative data set did not provide individual information such as the severity of the disease, dietary habits, or body mass index, which might potentially modify the relationship between OAG and dementia. Educational level that might impact both the risk of dementia and the recourse to care was further unavailable in our administrative data set. However, we adjusted for patient monthly income, urbanization level, and geographic location in the study to minimize the effect of sociodemographic characteristics. Third, previous population-based studies showed that approximately half of persons with glaucoma were undiagnosed. Therefore, subjects with undiagnosed OAG would have been categorized as non-OAG, and hence there is a possibility that diagnostic misclassification may have led to a spurious association between dementia and OAG. Similarly, underdiagnosis of dementia should be a concern. However, potential underdiagnosis and selection bias should be partly justified as the prevalence of dementia (3.9%, 12 147/307 672) and OAG (1.46%, 4489/307 672) during the study period (2005–2011) on population aged ≥45 years in our administrative claims, data were consistent with previous literature on the prevalence of dementia and OAG.
Fourth, there may be surveillance bias as patients with OAG are more likely to have frequent outpatient clinic visits, which may lead to early detection of dementia. However, we have adjusted for the number of outpatient visits within 1 year prior to index date. In addition, we examined the association between dementia and prior urinary calculi where a biological association is implausible. We found that there was no significant relationship between dementia and prior urinary calculi. Therefore, surveillance bias may not be a major reason contributing to the association found in the present study. Fifth, the study population mainly consisted of people of Chinese ethnicity, and it is unclear whether the results can be generalized to other ethnic populations. Finally, the data set only allowed us to trace the medical utilization of sampled patients back to 1996. Therefore, we could not ensure that cases and controls had no OAG or dementia prior to 1996, and this could have compromised our findings.
Despite these limitations, our nationwide population-based study found that female dementia patients were associated with a higher proportion of prior OAG than control among ethnic Chinese in Taiwan. Further studies are needed to confirm the association found in the present study and clarify the causal relationship.
Discussion
Currently available large epidemiologic data regarding the association between OAG and dementia were all obtained from Western populations, and results are controversial. In a longitudinal study using nationwide case register data of patients who had been hospitalized in Denmark, Kessing et al found that OAG was not associated with an increased risk of subsequent AD. However, the cases and controls were not matched in terms of sociodemographic characteristics or medical comorbidities, and there may have been a selection bias for patients with more-severe OAG. Similarly, Ou et al, using US Medicare claims data, also showed no increased risk of developing dementia after a diagnosis of OAG in nationally representative longitudinal cohorts of elderly persons. Ekström further identified a null association between OAG and AD in a population survey in the municipality of Tierp, Sweden. On the contrary, in a population-based longitudinal study in a French city that actively screened for glaucoma and dementia in elderly adults, Helmer et al showed a positive association between OAG and subsequent dementia. However, the study population mainly consisted of well-educated subjects and therefore the results might not be applicable to less-educated populations. To our best knowledge, this study is the first population-based study to investigate an epidemiologic association between OAG and dementia, after adjusting for patient sociodemographic characteristics and comorbid medical disorders in an Asian population. Consistent with the findings of Helmer et al, we demonstrated that a statistically significant higher proportion of prior OAG was found among dementia patients compared with the controls, which supports a possible association between OAG and dementia.
The actual mechanisms contributing to the association between OAG and dementia are not fully understood. There is an ample evidence suggesting that vascular risk factors including hypertension, diabetes, and hyperlipidemia are associated with cognitive impairment and increase the risk of AD and vascular dementia. Vascular risk factors contributing to vascular dysregulation and microvascular damage are also increasingly acknowledged as potential risk factors for the development and progression of OAG. Thus, a possible explanation regarding the association between OAG and dementia is that both diseases share common vascular risk factors. Our analysis adjusted for hypertension, diabetes, hyperlipidemia, and other vascular risk factors such as tobacco and alcohol use. It was suggested that vascular risk factors are not the sole mechanism contributing to the association between OAG and dementia.
In experimental studies using rat models, neurotoxic amyloid-β (Aβ), the core element of amyloid plaques in the AD brain, exhibited abnormal aggregation in retinal ganglion cells of eyes affected by elevated IOP. Activation of caspases, a group of proteases essential for apoptosis, that cleave amyloid precursor proteins into neurotoxic Aβ was also demonstrated in an ocular hypertensive model of rat glaucoma, implying a role of Aβ neurotoxicity in retinal ganglion cell death and the pathogenesis of glaucoma. Furthermore, there is emerging evidence that abnormal hyperphosphorylation of the microtubule-associated tau protein, a crucial injury marker of neuronal integrity and axonal transport in neurodegenerative diseases such as AD, was found in the retina of human glaucoma patients with elevated IOP. The presence of neurotoxic Aβ and hyperphosphorylated tau, major hallmarks of AD, in experimental rat and human retinas with elevated IOP, respectively, underscores the similarities between these two age-related neurodegenerative diseases at the molecular level. In addition to elevated IOP, decreased cerebrospinal fluid pressure, observed in a substantial proportion of patients with AD, results in an abnormal high trans-lamina cribrosa pressure difference and contributes to the development of glaucomatous damage to the optic nerve, suggesting a potential link between AD and OAG.
Another possible mechanism that links OAG to dementia is the severe vision loss and blindness caused by OAG in the elderly. Serious visual impairment, deprivation of an important structure critical for sensory input, is associated with limitations of the activities of daily living, and handicaps in physical and mental leisure activities, which may be helpful in enhancing the complexity of neuronal synapses, improving cognitive reserves, and eventually bringing about or aggravating cognitive impairment or dementia in older people. In addition, as the disease progresses, older people with visual impairment due to glaucoma are significantly afflicted by substantial psychological suffering, a poor quality of life, and depression, which are potential risk factors for AD and dementia. It is worth noting that female but not male dementia patients were more likely to have prior OAG than controls in our study. This observation can partially be explained by the gender effect in the progression of visual impairment due to glaucoma, and the lines of evidence show that older women are at greater risk for glaucoma vision loss. The mechanisms behind this may be a decline in female sex hormones after menopause, which may influence the IOP, increase vascular resistance, and hamper ocular blood flow to the optic nerve. As glaucoma more rapidly deteriorates in aged women, they are at a higher risk for dementia than men. As women exceed men in rapidly growing dementia populations, further research is needed to clarify the role of gender effects on the relationship between glaucoma and dementia.
A particular strength of this study is the use of a nationwide population-based data set that provided a sufficient sample size and statistical power to explore the association between OAG and dementia. However, the findings of this study need to be interpreted in the context of the following limitations. First, OAG and dementia diagnoses, which rely on administrative claims data and ICD codes, may be less precise than those made according to standardized diagnostic procedures including ophthalmologic and neuropsychological examinations. To avoid miscoding and increase the diagnostic accuracy, we selected patients who had at least two consensus diagnoses of OAG or dementia, and only dementia cases who were diagnosed by a certified neurologist or psychiatrist or only OAG cases who received prescriptions for topical antiglaucoma medication were included in the study. In order to address the appropriateness of using the applied coding approach, sensitivity analyses were performed using different definitions. We thus selected all subjects (n=17 292) who had received at least one diagnosis of dementia in their ambulatory care claims. We found that although the association magnitude decreased, there was still a significant association between dementia and OAG (adjusted OR=1.37 95% CI=1.28–1.46). In addition, to preclude inaccurate medical claims, the NHI Bureau of Taiwan randomly samples a fixed percentage of claims data with review and scrutiny of chart records from every hospital, followed by heavy penalties if outlier practice or malpractice is discovered. In addition, several previous studies determined that the NHI Research Database is of acceptable quality to provide reasonable estimates for epidemiological studies of OAG and dementia. Second, the administrative data set did not provide individual information such as the severity of the disease, dietary habits, or body mass index, which might potentially modify the relationship between OAG and dementia. Educational level that might impact both the risk of dementia and the recourse to care was further unavailable in our administrative data set. However, we adjusted for patient monthly income, urbanization level, and geographic location in the study to minimize the effect of sociodemographic characteristics. Third, previous population-based studies showed that approximately half of persons with glaucoma were undiagnosed. Therefore, subjects with undiagnosed OAG would have been categorized as non-OAG, and hence there is a possibility that diagnostic misclassification may have led to a spurious association between dementia and OAG. Similarly, underdiagnosis of dementia should be a concern. However, potential underdiagnosis and selection bias should be partly justified as the prevalence of dementia (3.9%, 12 147/307 672) and OAG (1.46%, 4489/307 672) during the study period (2005–2011) on population aged ≥45 years in our administrative claims, data were consistent with previous literature on the prevalence of dementia and OAG.
Fourth, there may be surveillance bias as patients with OAG are more likely to have frequent outpatient clinic visits, which may lead to early detection of dementia. However, we have adjusted for the number of outpatient visits within 1 year prior to index date. In addition, we examined the association between dementia and prior urinary calculi where a biological association is implausible. We found that there was no significant relationship between dementia and prior urinary calculi. Therefore, surveillance bias may not be a major reason contributing to the association found in the present study. Fifth, the study population mainly consisted of people of Chinese ethnicity, and it is unclear whether the results can be generalized to other ethnic populations. Finally, the data set only allowed us to trace the medical utilization of sampled patients back to 1996. Therefore, we could not ensure that cases and controls had no OAG or dementia prior to 1996, and this could have compromised our findings.
Despite these limitations, our nationwide population-based study found that female dementia patients were associated with a higher proportion of prior OAG than control among ethnic Chinese in Taiwan. Further studies are needed to confirm the association found in the present study and clarify the causal relationship.